ReviewParasites & vectors2025
Global distribution and impact of knockdown resistance mutations in Aedes aegypti on pyrethroid resistance.
Review in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Updated Adulticide Susceptibility Status of Florida Populations ofPathogens (Basel, Switzerland) · 2026Article
- CarE1 and GST1 Are Involved in Beta-Cypermethrin Resistance in Field Populations of the Mirid Bug,Insects · 2026Article
- Rising of pyrethroid resistance mutations (kdr) in the dengue vectorFrontiers in public health · 2026Article
- The contribution of transposable element insertions to genetic diversity inbioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The ongoing fight against mosquito-borne diseases such as dengue, Zika, and chikungunya is increasingly challenged by Aedes aegypti resistance to pyrethroid insecticides. This resistance is primarily driven by knockdown resistance (kdr) mutations in the voltage-gated sodium channel (Vgsc) gene, which have been identified in different regions with significant variability in their prevalence and impact. Managing Ae. aegypti populations in the face of this resistance require in-depth understanding of the global distribution of kdr mutations and their relationship to insecticide use patterns. This narrative review identifies a diverse landscape of kdr mutations, with common mutations such as V1016I, F1534C, and L982W, the latter of which has recently gained attention as an important mutation contributing to resistance in various regions, often co-occurring with other mutations and leading to enhanced resistance phenotypes. Additional mutations including V410L, G923V, S989P, I1011M/V, and D1763Y further complicate the resistance profile, indicating a dynamic evolution of resistance in response to pyrethroid use. This review also highlights significant gaps in current research, particularly in understanding the interaction between kdr mutations and other resistance mechanisms, such as metabolic detoxification by enzymes like cytochrome P450s, glutathione S-transferases (GST), and esterases, and the need for more standardized methodologies for data collection and reporting. The widespread use of pyrethroids has significantly contributed to the global spread of kdr mutations in Ae. aegypti, thereby challenging the efficacy of the current chemical vector control strategies. Despite these challenges, pyrethroids remain essential for mosquito control owing to their proven efficacy, rapid action, and versatility. However, the rising levels of resistance highlight the need for an integrated approach to vector management that combines chemical, biological, and community-based strategies. Future research should address these gaps through longitudinal studies and the development of new insecticides and resistance management strategies to address the growing threat of insecticide resistance in Ae. aegypti and protect public health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.